Citius Pharmaceuticals Inc.

CTXR | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.58

-$0.02 (-3.33%)

At close: Sep 21, 2026, 4:00 PM ET

$0.58

$0 (-0.60%)

Pre-market: Sep 22, 2026, 8:55 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.33%

(1D)

Rating

Updated: Sep 1, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $6.44M

1D Range

0.58 0.59

52W Range

0.47 2.19

Valuation (TTM)

PE -0.27

PB 0.10

EV/EBITDA 0.06

Valuation (NTM)

Forward PE 0.65

Forward PEG 0.01

Price Target $6

Cash Flow

FCF Yield -490.5%

SBC Adj. FCF Yield -702.8%

SBC Impact -43.3%

Margins

Gross Margin 20.0%

Operating Margin -857.0%

FCF Margin -444.7%

Growth (CAGR)

Revenue 3Y | 5Y 146.8% | 98.9%

Dil EPS 3Y | 5Y 29.9% | -36.0%

FCF 3Y | 5Y -2.3% | 19.6%

Returns

ROA -32.5%

ROE -67.2%

ROIC -67.6%

Financial Health

Net Cash

$9.83M

Current Ratio 0.84

Interest Coverage -88.28

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed tow...

Sector Healthcare

Industry Biotechnology

Employees 23

IPO Date Oct 1, 2014

Website www.citiuspharma.com

Fiscal Year October - September

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 17, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+934.48%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞